FDA Import Refusal AEK-5453890-3/11/1 — Abbvie Biotechnology Gmbh
The FDA refused shipment AEK-5453890-3/11/1 from Abbvie Biotechnology Gmbh (Germany) on Jul 17, 2024. The refused product falls under Drugs and Biologics — ADALIMUMAB. Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- Jul 17, 2024
- Country
- Germany
- Product Category
- Drugs and Biologics
- Product Code
- 58SCY14 ADALIMUMAB
- Charges
- 75